Suppr超能文献

立体定向消融放疗治疗临床局限性肾细胞癌

Stereotactic Ablative Radiotherapy for the Treatment of Clinically Localized Renal Cell Carcinoma.

作者信息

Campbell Scott P, Song Daniel Y, Pierorazio Phillip M, Allaf Mohamad E, Gorin Michael A

机构信息

The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.

Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.

出版信息

J Oncol. 2015;2015:547143. doi: 10.1155/2015/547143. Epub 2015 Nov 11.

DOI:10.1155/2015/547143
PMID:26640488
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4658408/
Abstract

Thermal ablation is currently the most studied treatment option for medically inoperable patients with clinically localized renal cell carcinoma (RCC). Recent evidence suggests that stereotactic ablative radiotherapy (SABR) may offer an effective noninvasive alternative for these patients. In this review, we explore the current literature on SABR for the primary treatment of RCC and make recommendations for future studies so that an accurate comparison between SABR and other ablative therapies may be conducted.

摘要

热消融是目前针对临床上局限性肾细胞癌（RCC）且医学上无法手术的患者研究最多的治疗选择。最近的证据表明，立体定向消融放疗（SABR）可能为这些患者提供一种有效的非侵入性替代方案。在本综述中，我们探讨了目前关于SABR用于RCC原发性治疗的文献，并对未来研究提出建议，以便能够对SABR与其他消融疗法进行准确比较。

相似文献

1
Stereotactic Ablative Radiotherapy for the Treatment of Clinically Localized Renal Cell Carcinoma.
J Oncol. 2015;2015:547143. doi: 10.1155/2015/547143. Epub 2015 Nov 11.
2
The Landscape of Stereotactic Ablative Radiotherapy (SABR) for Renal Cell Cancer (RCC).
Cancers (Basel). 2024 Jul 27;16(15):2678. doi: 10.3390/cancers16152678.
3
Stereotactic ablative radiotherapy for primary renal cell carcinoma.
Clin Transl Radiat Oncol. 2023 Nov 25;44:100705. doi: 10.1016/j.ctro.2023.100705. eCollection 2024 Jan.
4
A review of stereotactic ablative radiotherapy for nonmetastatic renal cell carcinoma.
World J Urol. 2024 Jan 20;42(1):52. doi: 10.1007/s00345-023-04731-2.
5
Is there a role for stereotactic radiotherapy in the treatment of renal cell carcinoma?
Clin Transl Radiat Oncol. 2019 Apr 26;18:104-112. doi: 10.1016/j.ctro.2019.04.012. eCollection 2019 Sep.
6
Robotic stereotactic ablative radiotherapy for renal cell carcinoma in patients with impaired renal function.
BMC Urol. 2019 Oct 21;19(1):96. doi: 10.1186/s12894-019-0531-z.
7
TROG 15.03 phase II clinical trial of Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney - FASTRACK II.
BMC Cancer. 2018 Oct 23;18(1):1030. doi: 10.1186/s12885-018-4916-2.
8
Stereotactic ablative radiation therapy in renal cell carcinoma: From oligometastatic to localized disease.
Crit Rev Oncol Hematol. 2017 Sep;117:48-56. doi: 10.1016/j.critrevonc.2017.07.004. Epub 2017 Jul 13.
9
The Judicious Use of Stereotactic Ablative Radiotherapy in the Primary Management of Localized Renal Cell Carcinoma.
Cancers (Basel). 2023 Jul 19;15(14):3672. doi: 10.3390/cancers15143672.
10
The emerging roles of stereotactic ablative radiotherapy for metastatic renal cell carcinoma.
Curr Opin Support Palliat Care. 2014 Sep;8(3):258-64. doi: 10.1097/SPC.0000000000000074.

引用本文的文献

1
Stereotactic Body Therapy for Urologic Cancers-What the Urologist Needs to Know.
Life (Basel). 2024 Dec 19;14(12):1683. doi: 10.3390/life14121683.
2
A 25 year perspective on the evolution and advances in an understanding of the biology, evaluation and treatment of kidney cancer.
Urol Oncol. 2021 Sep;39(9):548-560. doi: 10.1016/j.urolonc.2021.04.038. Epub 2021 Jun 4.
3
Renal cell carcinoma with isolated breast metastasis.
BMJ Case Rep. 2017 Jun 15;2017:bcr-2016-219124. doi: 10.1136/bcr-2016-219124.
4
[Focal therapy for small renal masses : Observation, ablation or surgery].
Urologe A. 2016 May;55(5):594-606. doi: 10.1007/s00120-016-0075-8.

本文引用的文献

1
Stereotactic radiation therapy combined with immunotherapy: augmenting the role of radiation in local and systemic treatment.
Oncology (Williston Park). 2015 May;29(5):331-40.
2
Kidney cancer, version 3.2015.
J Natl Compr Canc Netw. 2015 Feb;13(2):151-9. doi: 10.6004/jnccn.2015.0022.
3
EAU guidelines on renal cell carcinoma: 2014 update.
Eur Urol. 2015 May;67(5):913-24. doi: 10.1016/j.eururo.2015.01.005. Epub 2015 Jan 21.
4
Cancer statistics, 2015.
CA Cancer J Clin. 2015 Jan-Feb;65(1):5-29. doi: 10.3322/caac.21254. Epub 2015 Jan 5.
5
Stereotactic ablative body radiation therapy for primary kidney cancer: a 3-dimensional conformal technique associated with low rates of early toxicity.
Int J Radiat Oncol Biol Phys. 2014 Dec 1;90(5):1061-8. doi: 10.1016/j.ijrobp.2014.07.043. Epub 2014 Oct 13.
6
Renal cell carcinoma.
BMJ. 2014 Nov 10;349:g4797. doi: 10.1136/bmj.g4797.
7
Molecular aberrations, targeted therapy, and renal cell carcinoma: current state-of-the-art.
Cancer Metastasis Rev. 2014 Dec;33(4):1109-24. doi: 10.1007/s10555-014-9533-1.
8
Radiosurgical options in neuro-oncology: a review on current tenets and future opportunities. Part I: therapeutic strategies.
Tumori. 2014 Jul-Aug;100(4):459-65. doi: 10.1700/1636.17912.
9
Single fraction radiosurgery for the treatment of renal tumors.
J Urol. 2015 Mar;193(3):771-5. doi: 10.1016/j.juro.2014.08.044. Epub 2014 Aug 14.
10
The emerging roles of stereotactic ablative radiotherapy for metastatic renal cell carcinoma.
Curr Opin Support Palliat Care. 2014 Sep;8(3):258-64. doi: 10.1097/SPC.0000000000000074.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验